Effect of Dietary Fat on the Testosterone (T) Pharmacokinetics (PK) of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men.

被引:0
|
作者
Yin, A. [1 ,2 ]
Alfadhli, E. [1 ,2 ]
Htun, M. [1 ,2 ]
Dudley, R. E. [3 ]
Faulkner, S. [3 ]
Hull, L. [1 ,2 ]
Leung, A. [1 ,2 ]
Bross, R. [1 ,2 ]
Swerdloff, R. [1 ,2 ]
Wang, C. [1 ,2 ]
机构
[1] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Los Angeles BioMed Res Inst, Torrance, CA 90509 USA
[3] Clarus Therapeut Inc, Northbrook, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] EFFICACY AND PHARMACOKINETICS OF ORAL TESTOSTERONE (LPCN 1021) IN HYPOGONADAL MEN
    Chidambaram, N.
    Goldstein, I
    Dobs, A. S.
    Kaminetsky, J. C.
    Miner, M. M.
    Khera, M.
    Delconte, A.
    Chidambaram, N.
    Nachaegari, S.
    Patel, M.
    Wang, C.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S14 - S14
  • [22] SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS
    Swerdloff, R. S.
    Sulameh, W.
    Dohs, A.
    Faulknel, S.
    Dudley, R.
    Flippo, G.
    Kaminetsky, J.
    Armory, J.
    Honig, S. H.
    Danoff, T.
    Wang, C.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 150 - 150
  • [23] ASSESSMENT OF FASTING AND VARYING MEAL FAT CONTENT ON THE BIOAVAILABILITY OF ORAL TESTOSTERONE UNDECANOATE (LPCN 1021) IN HYPOGONADAL MEN
    Khera, M.
    Dobs, A. S.
    Miner, M. M.
    Wang, C.
    Delconte, A.
    Chidambaram, N.
    Nachaegari, S.
    Patel, M.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S18 - S18
  • [24] ORAL TESTOSTERONE UNDECANOATE (316 MG BID) QUICKLY AND EFFECTIVELY INCREASES SERUM TESTOSTERONE CONCENTRATIONS IN HYPOGONADAL MEN
    Khera, Mohit
    Boldt-Houle, Deborah M.
    Daugherty, Rhea
    Atkinson, Stuart N.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1073 - E1073
  • [25] Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men
    Jockenhoevel, F.
    Minnemann, T.
    Schubert, M.
    Freude, S.
    Huebler, D.
    Schumann, C.
    Christoph, A.
    Ernst, M.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (05) : 815 - 819
  • [26] Transdermal testosterone gel: Pharmacokinetics and efficacy of dosing and application site in hypogonadal men.
    Meikle, AW
    Matthias, D
    Hoffman, A
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S148 - S148
  • [27] Testosterone Pharmacokinetics (PK) in Older Men Participating in the Testosterone Trials (The T Trials)
    Swerdloff, Ronald S.
    Pak, Youngju
    Wang, Christina
    Liu, Peter Y.
    Bhasin, Shalender
    Gill, Thomas M.
    Matsumoto, Alvin M.
    Pahor, Marco
    Surampudi, Prasanth
    Romashkan, Sergei
    Hadley, Evan
    Snyder, Peter J.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [28] TREATMENT OF HYPOGONADAL MEN WITH ORAL TESTOSTERONE UNDECANOATE (TU) IMPROVES PSYCHO-SEXUAL, WELL-BEING AND BODY COMPOSITION PARAMETERS
    Honig, Stanton
    Jed, Kaminetsky
    Gittelman, Marc
    Swerdloff, Ronald
    Danoff, Theodore
    Dudley, Robert
    JOURNAL OF UROLOGY, 2020, 203 : E547 - E547
  • [29] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN WITH AND WITHOUT LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU)
    Saad, F.
    Doros, G.
    Haider, A.
    Haider, K.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S114 - S114
  • [30] Comparison of Long-Acting Testosterone Undecanoate Formulation Versus Testosterone Enanthate on Sexual Function and Mood in Hypogonadal Men Editorial Comment
    Seftel, Allen
    JOURNAL OF UROLOGY, 2009, 182 (04): : 1508 - 1509